Results 11 to 20 of about 1,273 (215)

Effectiveness of convalescent plasma therapy in eight non-intubated coronavirus disease 2019 patients in Indonesia: a case series

Journal of Medical Case Reports, 2021
Background Severe acute respiratory syndrome coronavirus 2, the cause of coronavirus disease 2019, has become a global pandemic. Currently, there is no definitive treatment for coronavirus disease 2019.
Theresia Monica Rahardjo, Elizabeth Yogipranata, Ardian Hediyanto Naswan, Fitri Rahayu Sari, Fajar Budiono, Hernawati Permatasari, C. H. R. Driantik Chuntari   +6 more
doaj   +1 more source

The Efficiency of Convalescent Plasma Therapy in the Management of Critically Ill Patients Infected With COVID-19: A Matched Cohort Study

Frontiers in Medicine, 2022
BackgroundThe convalescent plasma of patients who recover from coronavirus disease 2019 (COVID-19) contains high titers of neutralizing antibodies, which has potential effects on the viral shedding of severe acute respiratory syndrome coronavirus 2 (SARS-
Chun Pan, Hui Chen, Hui Chen, Jianfeng Xie, Yingzi Huang, Yi Yang, Bin Du, Haibo Qiu   +7 more
doaj   +1 more source

Convalescent plasma for patients with COVID-19 [PDF]

Proceedings of the National Academy of Sciences, 2020
The ongoing worldwide pandemic of coronavirus disease 2019 (COVID-19) (1), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has posed a huge threat to global public health, while no specific treatment is recommended for therapy (2).
Zeng, Furong, Chen, Xiang, Deng, Guangtong   +2 more
openaire   +2 more sources

Clinical nursing care protocol for convalescent plasma transfusion in patients with COVID-19

International Journal of Africa Nursing Sciences, 2023
Introduction: The treatment of COVID-19 is still challenge. So convalescent plasma can be an important alternative of treatment. Protocols with nursing care during infusion is very important to guide an effective and safety care Objective: to analyze the
Bruna Maiara Ferreira Barreto Pires, Ellen Marcia Peres, Antonio Marcos Tosoli Gomes, Norma Valéria Dantas de Oliveira Souza, Beatriz Guitton Renaud Baptista de Oliveira, Priscila Cristina da Silva Thiengo de Andrade, Thais Mayerhofer Kubota, Cristiene Faria, Dayana Carvalho Leite, Magno Conceição das Merces, Luana Ferreira de Almeida, Alessandra Sant'anna Nunes, Carolina Cabral Pereira da Costa, Lívia Fajin de Mello, Luciana Guimarães Assad, Silvia Maria de Sá Basílio Lins, Rafael Pires Silva, Ana Paula Oliveira Motta, Cristiano Bertolossi Marta, Vanessa Galdino de Paula, Raquel de Souza Ramos, Mauricio Cupello Peixoto, Mônica Oliveira Duarte Martins, Alexandrina de Aguiar Ciríaco, Patrícia Britto Ribeiro de Jesus, Ariane da Silva Pires, Eugênio Perez Fuentes Junior, Helena Ferraz Gomes   +27 more
doaj   +1 more source

COVID-19 convalescent plasma

Blood, 2022
AbstractAs the coronavirus disease (COVID-19) pandemic led to a global health crisis, there were limited treatment options and no prophylactic therapies for those exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Convalescent plasma is quick to implement, potentially provides benefits, and has a good safety profile.
Aaron A. R. Tobian, Claudia S. Cohn, Beth H. Shaz   +2 more
openaire   +3 more sources

Rates Among Hospitalized Patients With COVID-19 Treated With Convalescent Plasma: A Systematic Review and Meta-Analysis

Mayo Clinic Proceedings: Innovations, Quality & Outcomes, 2023
Objective: To examine the association of COVID-19 convalescent plasma transfusion with mortality and the differences between subgroups in hospitalized patients with COVID-19.
Jonathon W. Senefeld, PhD, Ellen K. Gorman, BS, Patrick W. Johnson, BS, M. Erin Moir, PhD, Stephen A. Klassen, PhD, Rickey E. Carter, PhD, Nigel S. Paneth, MD, David J. Sullivan, MD, Olaf H. Morkeberg, BA, R. Scott Wright, MD, DeLisa Fairweather, PhD, Katelyn A. Bruno, PhD, Shmuel Shoham, MD, Evan M. Bloch, MBChB, MS, Daniele Focosi, MD, Jeffrey P. Henderson, MD, PhD, Justin E. Juskewitch, MD, PhD, Liise-Anne Pirofski, MD, Brenda J. Grossman, MD, MPH, Aaron A.R. Tobian, MD, PhD, Massimo Franchini, MD, Ravindra Ganesh, MBBS, MD, Ryan T. Hurt, MD, PhD, Neil E. Kay, MD, Sameer A. Parikh, MBBS, Sarah E. Baker, PhD, Zachary A. Buchholtz, BS, Matthew R. Buras, BS, Andrew J. Clayburn, BS, Joshua J. Dennis, BS, Juan C. Diaz Soto, MD, Vitaly Herasevich, MD, PhD, Allan M. Klompas, MB, BCh, BAO, Katie L. Kunze, PhD, Kathryn F. Larson, MD, John R. Mills, PhD, Riley J. Regimbal, BS, Juan G. Ripoll, MD, Matthew A. Sexton, MD, John R.A. Shepherd, MD, James R. Stubbs, MD, Elitza S. Theel, PhD, Camille M. van Buskirk, MD, Noud van Helmond, MD, Matthew N.P. Vogt, MD, Emily R. Whelan, BS, Chad C. Wiggins, PhD, Jeffrey L. Winters, MD, Arturo Casadevall, MD, PhD, Michael J. Joyner, MD   +49 more
doaj   +1 more source

Correspondence on ‘CONVALESCENT plasma for COVID‐19’ [PDF]

European Journal of Clinical Investigation, 2021
we would like to share ideas on the publication "CONVALESCENT plasma for COVID-19: A meta-analysis of clinical trials and real-world evidence [1]." Kloypan et al. reported that "7,118 patients received convalescent plasma (CP) and 7,780 patients received standard treatment" and found that "Patients treated with CP had a lower mortality rate than those ...
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit   +1 more
openaire   +2 more sources

Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial

BMJ Medicine, 2023
Objective To evaluate the efficacy of covid-19 convalescent plasma to treat patients admitted to hospital for moderate covid-19 disease with or without underlying immunodeficiency (CORIPLASM trial).Design Open label, randomised clinical trial.Setting ...
Arsène Mekinian, Xavier Mariette, Florence Ader, Raphaël Porcher, Philippe Ravaud, Lionel Piroth, Gabriel Baron, Jean-Marie Michot, Karine Lacombe, Tabassome Simon, Sophie Georgin-Lavialle, Charles Cazanave, Marc Michel, Olivier Hermine, Guillaume Martin-Blondel, Fabrice Bonnet, Pierre Tiberghien, Xavier Lescure, Xavier de Lamballerie, Valérie Pourcher, Matthieu Resche-Rigon, Thibault Chiarabini, Stella Rousset, Fanny Pommeret, Thomas Hueso, Julien Saison, Nathalie De Castro, Anne Francois, Pascal Morel, Nora Soussi, Phillipe Brun, Pierre Sellier, Pierre-Louis Tharaux   +32 more
doaj   +1 more source

Outcome of Indoor Covid Cases with Moderate to Severe Disease; Convalescent Plasma Transfusion vs Conventional Therapy

Journal of Bahria University Medical and Dental College, 2022
Objectives: Global COVID-19 epidemic has been therapeutic challenge. Convalescent plasma is observed to improve clinical outcomes. This research aims to study whether convalescent plasma therapy reduces the mortality and duration of hospitalization in ...
Lubna Meraj , Muhammad Usman, Nadia Shams, Muhammad Umar, Sidra Tahir, Nasim Akhtar, Muhammad Khalid Mehmood Randhawa, Asif Majid, Ashar Alamgir   +8 more
doaj   +1 more source

Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals

mBio, 2020
In the absence of effective vaccines and with limited therapeutic options, convalescent plasma is being collected across the globe for potential transfusion to coronavirus disease 2019 (COVID-19) patients.
Guillaume Beaudoin-Bussières, Annemarie Laumaea, Sai Priya Anand, Jérémie Prévost, Romain Gasser, Guillaume Goyette, Halima Medjahed, Josée Perreault, Tony Tremblay, Antoine Lewin, Laurie Gokool, Chantal Morrisseau, Philippe Bégin, Cécile Tremblay, Valérie Martel-Laferrière, Daniel E. Kaufmann, Jonathan Richard, Renée Bazin, Andrés Finzi   +18 more
doaj   +1 more source